Lung Cancer and Personalized Medicine: Novel Therapies and Clinical Management
This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical manageme...
| Corporate Author: | |
|---|---|
| Other Authors: | , |
| Language: | English |
| Published: |
Cham :
Springer International Publishing : Imprint: Springer,
2016.
|
| Edition: | 1st ed. 2016. |
| Series: | Advances in Experimental Medicine and Biology,
890 |
| Subjects: | |
| Online Access: | https://doi.org/10.1007/978-3-319-24932-2 |
| Summary: | This, the second of two volumes on personalized medicine in lung cancer, touches upon the recent progress in targeted drug development based on genomics; emerging biomarkers and therapeutic targets such as EMT, cancer stem cells, and the tumor microenvironment; current personalized clinical management and radiation therapy for lung cancers; and the promise of epigenetics and next-generation sequencing for the advancements towards personalized therapy of lung cancer patients. With chapters on state-of-the-art therapies and technologies written by leading experts working to develop novel companion diagnosis tools for the personalized treatment of lung cancer patients, this volume brings readers up-to-date by presenting the current knowledge on the efforts to make personalized management of lung cancer patients a reality. . |
|---|---|
| Physical Description: | X, 231 p. 22 illus., 21 illus. in color. online resource. |
| ISBN: | 9783319249322 |
| ISSN: | 0065-2598 ; |